PEG-Conjugated Fab Fragments Inhibit Non-Specific Reactions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing immunological measurement methods face challenges with non-specific reactions, particularly due to the presence of human IgM or IgG, which can lead to inaccurate results and secondary immunological nephelometric reactions, and current inhibitors like antibodies or their fragments are either ineffective or unstable.
Innovation Solution
Chemically linking polymers, such as polyethylene glycol, to antibody fragments like Fab′ to increase their molecular size and stability, thereby enhancing their ability to inhibit non-specific reactions without causing nephelometric reactions, even at low concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibodies or antibody fragments are used to inhibit non-specific reactions, then non-specific reactions are inhibited, but immunological nephelometric reactions occur causing cloudiness and inaccurate measurements
Solution Approach 1:
The patent extracts and removes the Fc region from the antibody structure, using only the Fab fragment as the inhibitor. This extraction eliminates the harmful Fc region that causes immunological nephelometric reactions while retaining the antigen-binding capability needed for non-specific reaction inhibition
Solution Approach 2:
The patent changes the molecular structure parameter by using Fab fragments instead of whole antibodies, and further modifies it by conjugating the Fab fragments to polyethylene glycol (PEG). This parameter change reduces molecular size and eliminates the Fc region's harmful effects while maintaining inhibitory function
2Object-affected harmful factors
If Fab fragments are used as inhibitors, then immunological nephelometric reactions are avoided, but the inhibitors are unstable and easily degraded
Solution Approach 1:
The patent creates a composite material by conjugating Fab fragments with polyethylene glycol (PEG). This composite structure combines the antigen-binding capability of the Fab fragment with the stability and solubility-enhancing properties of PEG, resulting in an inhibitor that is both stable and effective
Solution Approach 2:
The PEG conjugation provides beforehand cushioning protection to the Fab fragment, shielding it from degradation and improving its stability in the measurement system before any degradation can occur
3Reliability
If conventional antibodies are used to inhibit non-specific reactions, then non-specific reactions are inhibited, but large amounts are required which may cause secondary reactions
Solution Approach 1:
By extracting and removing the Fc region to use only Fab fragments, the patent reduces the amount of inhibitor needed while maintaining effectiveness, as the Fab fragments are more efficient at blocking non-specific reactions without causing the harmful effects of whole antibodies
Solution Approach 2:
The patent changes the molecular weight and structure parameters by using PEG-conjugated Fab fragments, which improves the efficiency of non-specific reaction inhibition and reduces the quantity required compared to conventional antibodies
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer-modified antibody fragments effectively inhibit non-specific reactions with significantly reduced amounts compared to conventional antibodies, maintaining stability and preventing immunological nephelometric reactions, thus providing accurate measurements.
Implementation Method 1
Chemically linking polymers, such as polyethylene glycol, to antibody fragments like Fab′ to increase their molecular size and stability
Implementation Method 2
an antigen-antibody reaction, there has been a problem that some samples which do not contain an antigen to be measured show positive measured values
Data Source
AI summary
Disclosed is a non-specific reaction inhibitor for use in an immunological measurement, comprising a complex of an antibody or a fragment of the antibody capable of specifically binding to a non-specific reaction factor, and a polymer. The non-specific reaction inhibitor can inhibit a non-specific reaction which may interfere with the accurate detection or quantification of a trace substance in an immunological measurement method.